STOCK TITAN

iAnthus Securityholders Overwhelmingly Approve Recapitalization Transaction

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

On September 14, 2020, iAnthus Capital Holdings announced overwhelming approval from Securityholders for a recapitalization transaction via a court-approved plan under British Columbia's Business Corporations Act. Secured Noteholders and Unsecured Debentureholders voted 100% in favor, while 79% of Existing Equityholders supported the plan, significantly exceeding minority approval requirements. A court hearing for final approval is scheduled for September 25, 2020. The transaction may require state-level regulatory review in various U.S. states where iAnthus operates.

Positive
  • 100% approval from Secured Noteholders and Unsecured Debentureholders for the recapitalization plan.
  • 79% support from Existing Equityholders, surpassing required minority approval.
Negative
  • Potential delays due to required state-level regulatory approval in multiple jurisdictions.
  • Business interruptions from COVID-19 could adversely impact operations and financial results.

NEW YORK and TORONTO, Sept. 14, 2020 /PRNewswire/ - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCQX: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, announces that, at the meetings of Secured Noteholders, Unsecured Debentureholders and Existing Equityholders (each as defined below and, collectively, the "Securityholders") held on September 14, 2020, Securityholders voted overwhelmingly in support of the previously announced recapitalization transaction (the "Recapitalization Transaction") to be implemented by way of a court-approved plan of arrangement under the British Columbia Business Corporations Act (the "Plan of Arrangement").

Approval of the Plan of Arrangement

At the meeting of holders (the "Secured Noteholders") of the 13% senior secured convertible debentures (the "Secured Notes") issued by iAnthus Capital Management, LLC ("ICM"), the Company's wholly-owned US subsidiary, 100% of the votes cast by Secured Noteholders (representing all of the outstanding Secured Notes) were voted in favour of the Plan of Arrangement.

At the meeting of holders (the "Unsecured Debentureholders") of the 8% convertible unsecured debentures (the "Unsecured Debentures") issued by the Company, 100% of the votes cast by Unsecured Debentureholders (representing all of the outstanding Unsecured Debentures) were voted in favour of the Plan of Arrangement.

At the meeting (the "Equityholders' Meeting") of holders of the Company's common shares (the "Common Shares"), options (the "Options") and warrants (the "Warrants") (collectively, the "Existing Equityholders"), 79.0% of the votes cast by Existing Equityholders, present in person or by proxy at the Equityholders' Meeting, voting together as a single class, were voted in favour of the Plan of Arrangement. In addition, 66.3% of the votes cast by holders of Common Shares, present in person or by proxy at the Equityholders' Meeting, excluding votes of Common Shares beneficially owned or over which control or direction is exercised by Related Shareholders, were voted in favour of the Plan of Arrangement, which significantly exceeds the minority approval requirements (50% + 1) of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101") of the Canadian Securities Administrators. When Related Shareholders are included, a total of 68.3% of the votes cast by holders of Common Shares, present in person or by proxy at the Equityholders' Meeting, were voted in favour of the Plan of Arrangement.

The term "Related Shareholders" means, in respect of the Company, "interested parties", "related parties" of any interested parties (unless the related party meets that description solely in its capacity as a director or senior officer of one or more persons that are neither interested parties nor issuer insiders of the Company) and "joint actors" of the foregoing (as such terms are defined in MI 61-101). To the knowledge of the Company after reasonable inquiry, the only Related Shareholders who beneficially owned or exercised control or direction over Common Shares at the time of the Equityholders' Meeting were funds affiliated with Gotham Green Partners, LLC.

Court Approval and Implementation

The Company and ICM will attend a hearing before the Supreme Court of British Columbia (the "Court") currently scheduled for 10:00 a.m. (Vancouver time) on September 25, 2020, or such other time and date as may be set by the Court, to seek final Court approval for the Plan of Arrangement (the "Final Order"). 

Certain of the transactions contemplated by the Recapitalization Transaction may trigger a review and approval requirement by state-level regulators in certain U.S. states with jurisdiction over the licensed cannabis operations of entities owned in whole or in part or controlled directly or indirectly by iAnthus, including potentially: Arizona, Florida, Maryland, Massachusetts, Nevada, New Jersey, New York, and Vermont. Where required, iAnthus intends to promptly commence the review and approval process and to expedite the process to the greatest extent possible.

About iAnthus

iAnthus owns and operates licensed cannabis cultivation, processing and dispensary facilities throughout the United States, providing investors diversified exposure to the U.S. regulated cannabis industry. Founded by entrepreneurs with decades of experience in operations, investment banking, corporate finance, law and healthcare services, iAnthus provides a unique combination of capital and hands-on operating and management expertise. iAnthus currently has a presence in 11 states and operates 36 dispensaries (AZ-4, MA-1, MD-3, FL-16, NY-3, CO-1, VT-1 and NM-7 where iAnthus has minority ownership). For more information, visit www.iAnthus.com.

COVID-19 Risk Factor

The Company may be impacted by business interruptions resulting from pandemics and public health emergencies, including those related to COVID-19. An outbreak of infectious disease, a pandemic, or a similar public health threat, such as the recent outbreak of COVID-19, or a fear of any of the foregoing could adversely impact the Company by causing operating, manufacturing, supply chain, and project development delays and disruptions, labor shortages, travel, and shipping disruption and shutdowns (including as a result of government regulation and prevention measures). It is unknown whether and how the Company may be affected if such a pandemic persists for an extended period of time, including as a result of the waiver of regulatory requirements or the implementation of emergency regulations to which the Company is subject. Although the Company has been deemed essential and/or has been permitted to continue operating its facilities in the states in which it cultivates, processes, manufactures, and sells cannabis during the pendency of the COVID-19 pandemic, there is no assurance that the Company's operations will continue to be deemed essential and/or will continue to be permitted to operate. The Company may incur expenses or delays relating to such events outside of its control, which could have a material adverse impact on its business, operating results, financial condition, and the trading price of the Common Shares.

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties, including concerning COVID-19 and the specific factors disclosed here and elsewhere in iAnthus' periodic filings with Canadian securities regulators. When used in this news release, words such as "will", "hope", "could", "plan", "estimate", "expect", "intend", "may", "potential", "believe", "should", "our vision" and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, the timing and outcome of Court approval of the Plan of Arrangement, the timing and outcome of required U.S. state regulatory approvals and the implementation and completion of the Recapitalization Transaction.

Readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. iAnthus disclaims any intention or obligation to update or revise such information, except as required by applicable law, and iAnthus does not assume any liability for disclosure relating to any other company mentioned herein.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

The securities to be issued pursuant to the Restructuring Transaction have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold within the United States or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws, or an exemption from such registration is available.  This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities.  "United States" and "U.S. person" are as defined in Regulation S under the U.S. Securities Act.

Cision View original content:http://www.prnewswire.com/news-releases/ianthus-securityholders-overwhelmingly-approve-recapitalization-transaction-301130657.html

SOURCE iAnthus Capital Holdings, Inc.

FAQ

What was the result of the iAnthus recapitalization transaction vote on September 14, 2020?

On September 14, 2020, iAnthus reported 100% approval from Secured Noteholders and Unsecured Debentureholders, with 79% of Existing Equityholders supporting the recapitalization transaction.

When is the court hearing for final approval of the iAnthus recapitalization plan?

The court hearing for final approval of the iAnthus recapitalization plan is scheduled for September 25, 2020.

What regulatory approvals may affect iAnthus operations after the recapitalization?

Post-recapitalization, iAnthus may require regulatory approvals from state-level authorities in U.S. states where it operates.

How could COVID-19 impact iAnthus' business operations?

COVID-19 may cause operating delays, labor shortages, and other disruptions that could adversely affect iAnthus' financial performance.

IANTHUS CAPITAL HLDG ORD

OTC:ITHUF

ITHUF Rankings

ITHUF Latest News

ITHUF Stock Data

33.39M
3.61B
7.34%
85.18%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Toronto